Alzheimer's disease lymphocytes: potential for biomarkers?-Reference-Cited by-同舟云学术

Alzheimer's disease lymphocytes: potential for biomarkers?

Published:2016-01 Issue:1 Volume:10 Page:1-4
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Wojda Urszula¹

Affiliation:

1. Laboratory of Preclinical Testing of Higher Standard, Neurobiology Center, Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/bmm.15.79

Reference20 articles.

1. Alzheimer Disease International: Dementia statistics. http://www.alz.co.uk/research/statistics.

2. Monetary Costs of Dementia in the United States

3. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

4. Pathways to Alzheimer's disease

5. The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matching science to reality: how to deploy a participant-driven digital brain health platform;Frontiers in Dementia;2023-05-05

2. Cholesterol dysregulation in peripheral blood mononuclear cells of Alzheimer's disease;Journal of Neuroimmunology;2022-12

3. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects;Biology;2022-01-28

4. The association between blood lymphocyte NMDAR, group I mGluRs and cognitive function changes in occupationally aluminum-exposed workers and verification in rats;Journal of Trace Elements in Medicine and Biology;2022-01

5. Sirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases;Biomedicines;2021-10-29